NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Atmel (ATML) was downgraded at FBR Capital Markets from outperform to market perform. $7.50 price target. Company may lose market share in the near term, FBR Capital Markets said.
AZZ (AZZ) was upgraded from neutral to buy at DA Davidson. Estimates were also boosted, as the recent acquisition should add to earnings. DA Davidson said.Chemtura (CHMT) was downgraded at Oppenheimer to perform from outperform. Approaching limits to further margin improvement, Oppenheimer said. Colgate-Palmolive (CL - Get Report) was downgraded at Bank of America/Merrill Lynch from buy to neutral. $119 price target. Company is facing difficult comps and a currency headwind, BofA/Merrill Lynch said. CVR Refining (CVRR) was initiated with a neutral rating at Citigroup. $30 price target. Highly defensible position with modest upside, Citi said. CVR Refining LP was initiated with a buy rating at UBS. $31 price target. Yielding fruit of Midwest refining bonanza. Ford (F) was upgraded to buy at TheStreet Ratings. GM (GM) was upgraded to buy at TheStreet Ratings. Intel (INTC - Get Report) was upgraded at Drexel Hamilton from sell to hold. $22 price target. Altera foundry deal should help future earnings, Drexel Hamilton said. LSI (LSI) was downgraded at FBR Capital Markets from outperform to market perform. $8 price target. Company is facing increased competition, FBR Capital Market said. Altria (MO - Get Report) was downgraded at Bank of America/Merrill Lynch from buy to neutral. $36 price target. Company will likely face increased competition from RAI, BofA/Merrill Lynch said. Rosetta Resources (ROSE) was downgraded at Miller Tabak to sell. $41 price target. Company is running out of oil inventory, Miller Tabak said. Suntrust Banks (STI - Get Report) was upgraded at FIG Partners to outperform. $32 price target. Expect positive results from the CCAR stress test, FIG Partners said.
STOCK COMMENTS / EPS CHANGESAutodesk (ADSK) estimates, price target were raised at Credit Suisse. Shares are now seen reaching $35. Estimates were also increased, as the company is signing more large deals, Credit Suisse said. Amgen (AMGN) estimates, target boosted at Guggenheim. Shares are now seen reaching $95. Estimates were also increased, as Epogen is facing less competition, following the Omontys recall, Guggenheim said. Neutral rating. Best Buy (BBY) price target was raised at UBS. Shares are now seen reaching $18. Prolonged stability is now needed to justify BBY's price move, UBS said. Neutral rating. Chuy's Holdings (CHUY) numbers were raised at Jefferies. Shares are now seen reaching $25. Estimates were also raised on unit growth. Hold rating. Capital One Financial (COF) numbers were lowered at Jefferies. Shares are now seen reaching $60. Estimates were also lowered on Best Buy card portfolio sale. Buy rating. Darden Restaurants (DRI) numbers were lowered at Oppenheimer. Shares are now seen reaching $51. Estimates were also lowered on uncertainty surrounding EPS growth, Oppenheimer said. Outperform rating. FirstEnergy (FE) numbers were cut at Credit Suisse. Shares are now seen reaching $46. Estimates were also reduced, as the company will likely issue more equity later this year, Credit Suisse said. Outperform rating. JM Smucker (SJM) numbers were increased at Keybanc. Estimates were raised through 2014. Company is focused on organic growth and improving efficiency, Keybanc said. Buy rating and new $100 price target. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.